Concord, MA · Founded 2020 · Privately Held (backing)
Operator of a biopharmaceutical company intended to develop an investigational siRNA medicine for preterm preeclampsia. Comanche Biopharma is based in Concord, MA and was founded in 2020. It was valued at $210 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $136 million across 2 recorded rounds; the latest was a $37.5 million early-stage round in Dec 2023.
PMV mark · valuation
$210.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$136.1M
Last round
Early Stage VC
Dec 2023
Cap table — not yet on record
Comanche Biopharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Comanche Biopharma with a free account
·Watch Comanche Biopharma: the Monday email on marks, rounds and moves
Where does Comanche Biopharma's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Comanche Biopharma's 2 recorded funding rounds.
